echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Dig Dis Sci: Spontaneous HBsAg seroclearance is associated with lower liver fibrosis in patients with chronic hepatitis B

    Dig Dis Sci: Spontaneous HBsAg seroclearance is associated with lower liver fibrosis in patients with chronic hepatitis B

    • Last Update: 2022-05-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Chronic hepatitis B virus (HBV) infection is a major health problem worldwide as it can lead to various complications including liver cirrhosis, liver failure and hepatocellular carcinoma (HCC), resulting in severe disease burden, death rate and morbidity


    Chronic hepatitis B virus (HBV) infection is a major health problem worldwide as it can lead to various complications including liver cirrhosis, liver failure and hepatocellular carcinoma (HCC), resulting in severe disease burden, death rate and morbidity


    We retrospectively matched 23 consecutive HBsAg serocleared patients in a 1:3 ratio who underwent transient elastography in a community hospital between March 2008 and August 2021


     

    A total of 23 cases and 69 control cases were included in this study


    diabetes

     

    This study found that spontaneous HBsAg seroclearance remains rare in patients with chronic HBV infection, but it was associated with low baseline HBsAg and lower levels of liver fibrosis detected by TE


    This study found that spontaneous HBsAg seroclearance remains rare in patients with chronic HBV infection, but it was associated with low baseline HBsAg and lower levels of liver fibrosis detected by TE


    Original source:

    Sammy Saab.


    Sammy Saab.
    Et al.
    Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naïve Chronic Hepatitis B Patients.
    Digestive Diseases and Sciences.
    2022.
    Spontaneous Seroclearance Is Associated with Lower Liver Fibrosis in Treatment-Naïve Chronic Hepatitis B Patients.


    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.